208 related articles for article (PubMed ID: 7194803)
1. Lysis of clots prepared from whole blood and plasma.
Taylor FB; Carroll RC; Gerrard J; Esmon CT; Radcliffe RD
Fed Proc; 1981 May; 40(7):2092-8. PubMed ID: 7194803
[No Abstract] [Full Text] [Related]
2. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
van Giezen JJ; Minkema J; Bouma BN; Jansen JW
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):869-75. PubMed ID: 7511944
[TBL] [Abstract][Full Text] [Related]
3. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
Reed GL; Matsueda GR; Haber E
Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
[No Abstract] [Full Text] [Related]
4. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
Reed GL; Matsueda GR; Haber E
Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
[TBL] [Abstract][Full Text] [Related]
6. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method].
Ogloblina OG; Saburova OS; Semenova OA; Belova LA
Biokhimiia; 1994 Jan; 59(1):62-8. PubMed ID: 7509643
[TBL] [Abstract][Full Text] [Related]
7. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
Aoki N
Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
[No Abstract] [Full Text] [Related]
8. Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
Zabczyk M; Natorska J; Bagoly Z; Sarkady F; Barath B; Katona E; Bryk A; Zettl K; Wisniewski JR; Undas A
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33214340
[TBL] [Abstract][Full Text] [Related]
9. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
Devine DV; Bishop PD
Semin Thromb Hemost; 1996; 22(5):409-13. PubMed ID: 8989824
[TBL] [Abstract][Full Text] [Related]
10. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
Lockhart MS; Comp PC; Taylor FB
J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of alpha 2-plasmin inhibitor].
Mimuro J; Aoki N
Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
[No Abstract] [Full Text] [Related]
12. Fibrin network structure: modification by platelets.
Dhall TZ; Shah GA; Ferguson IA; Dhall DP
Thromb Haemost; 1983 Feb; 49(1):42-6. PubMed ID: 6845271
[TBL] [Abstract][Full Text] [Related]
13. The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII.
Kluft C; Los P; Jie AF
Thromb Res; 1984 Feb; 33(4):419-25. PubMed ID: 6710441
[TBL] [Abstract][Full Text] [Related]
14. Clinically mild thrombasthenia with normal platelet coagulant activities.
Walsh PN; Rizza CR; McLennan R
Thromb Diath Haemorrh; 1972 Dec; 28(3):440-6. PubMed ID: 4649278
[No Abstract] [Full Text] [Related]
15. [Behavior of leukocytes towards blood platelets and during retraction].
Lindner E; Marcsek M; Dierichs R
Verh Anat Ges; 1976; (70 Pt 2):945-53. PubMed ID: 1024395
[No Abstract] [Full Text] [Related]
16. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
Robbie LA; Booth NA; Croll AM; Bennett B
Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
[TBL] [Abstract][Full Text] [Related]
17. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction.
Joist JH; Niewiarowski S
Thromb Diath Haemorrh; 1973 Jun; 29(3):679-83. PubMed ID: 4271547
[No Abstract] [Full Text] [Related]
18. Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation.
Glover CJ; McIntire LV; Brown CH; Natelson EA
Thromb Res; 1975 Jul; 7(1):185-98. PubMed ID: 1154337
[No Abstract] [Full Text] [Related]
19. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
20. Clot retraction facilitates clot lysis.
Carroll RC; Gerrard JM; Gilliam JM
Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
